Midodrine hydrochloride

盐酸甲氧胺福林

Report date: 2026/05/23 20:00:57
NME

Base Information

Drug NameMidodrine hydrochloride
Drug Alias Namemidodrina盐酸米多君midodrinum米多君Gudon +[15] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha adrenergic receptor agonists
TargetsAlpha adrenergic receptor
Therapy Area/IndicationsAscitesHypotensionVentricular Dysfunction, Left +[14] 
Global Approved IndicationsHypotensionHypotension, Orthostatic
Approved Indications in ChinaHypotensionHypotension, Orthostatic
Original Approved Country/TerritoryUnited States
Original Approved Date1996/09/06
Country/TerritoryUnited StatesMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShire
China Registration ClassN/A

Develop Information

Active CompaniesShire PharmaceuticalsVanderbilt University Medical CenterIcahn School Of Medicine At Mount Sinai +[6] 
Inactive CompaniesTakeda Pharmaceuticals USA IncMylan Pharmaceuticals IncPostgraduate Institute Of Medical Education And Research +[5] 
Active IndicationsHypotensionVentricular Dysfunction, LeftHeart Failure, Systolic +[12] 
Inactive IndicationsAscitesShock, Septic

Other Information

ATC CodeC01CA17
Related LinksWikipediaDrugBankKEGG